These Analysts Slash Their Forecasts On Insulet After Q2 Results
Insulet Corp. (NASDAQ:PODD) reported strong Q2 earnings but lowered revenue outlook for 2021. Analysts downgraded stock and lowered price targets.
Insulet had a good quarter, but told everyone it won't make as much money this year as people thought. Because of this bad news about the future, experts lowered how much they think the stock is worth.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.